Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension

Breast density tends to decrease when women stop taking hormone therapy (HT). Some women find HT cessation difficult to tolerate, possibly because of fluctuations in endogenous hormone levels and vasomotor symptoms. We hypothesized that women with dense breasts might have lower tolerance for short-t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of women's health (Larchmont, N.Y. 2002) N.Y. 2002), 2010-08, Vol.19 (8), p.1467-1474
Hauptverfasser: Aiello Bowles, Erin J, Anderson, Melissa L, Reed, Susan D, Newton, Katherine M, Fitzgibbons, E Dawn, Seger, Deborah, Buist, Diana S M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1474
container_issue 8
container_start_page 1467
container_title Journal of women's health (Larchmont, N.Y. 2002)
container_volume 19
creator Aiello Bowles, Erin J
Anderson, Melissa L
Reed, Susan D
Newton, Katherine M
Fitzgibbons, E Dawn
Seger, Deborah
Buist, Diana S M
description Breast density tends to decrease when women stop taking hormone therapy (HT). Some women find HT cessation difficult to tolerate, possibly because of fluctuations in endogenous hormone levels and vasomotor symptoms. We hypothesized that women with dense breasts might have lower tolerance for short-term HT suspension than do women with fatty breasts. As part of the Radiologic Evaluation And breast Density (READ) trial, we randomly assigned 881 women aged 45-80 with a prior screening (index) mammogram to suspend HT for 1 or 2 months before their next screening (study) mammogram. We measured continuous breast density on index mammograms using computer-assisted thresholding. At study mammograms, women indicated tolerance for stopping HT from 1 (extremely difficult) to 7 (very easy). Using linear regression, we evaluated the association between index breast density and tolerance after cessation, adjusting for age, body mass index (BMI), HT type, randomization group, and vasomotor symptoms. A higher percentage of breast density was associated with lower unadjusted mean tolerance scores (tolerance 4.27, 95% confidence interval [CI] 3.77-4.77 for women with > or =50% density, and 4.73, 95% CI 4.45-5.01 for women with
doi_str_mv 10.1089/jwh.2009.1681
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2941404</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748935436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-2396cd8faec3943db8e9bd19a6d18dafdd5995a9aa91be78d528b02443427af33</originalsourceid><addsrcrecordid>eNpVkUtr3TAQRkVIyXuZbdEuK9_oZVvaBEpIm0BCNy1kJ8bWOHawJUeSU-6_jy9JQ7uage_wzcAh5JyzDWfaXD7_6TeCMbPhleZ75IgbyQut5OP-upeKFcaY6pAcp_TMmBCcsQNyKFhZlzXnR6R5gGkKTxHmfmhpExFSpg59GvKWgnc0hxEj-BZpFyJNfYi5yBgnOoeUJ_RhhiXBSNdgCh5p7ld83tK0pHlXE_wp-dLBmPDsY56Q399vfl3fFvc_f9xdf7svWqmrXAhpqtbpDrCVRknXaDSN4wYqx7WDzrnSmBIMgOEN1tqVQjdMKCWVqKGT8oRcvffOSzOha9HnCKOd4zBB3NoAg_0_8UNvn8KrFUZxxdRacPFREMPLginbaUgtjiN4DEuytdJGlkpWK1m8k20MKUXsPq9wZnda7KrF7rTYnZaV__rva5_0Xw_yDbZRjX4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748935436</pqid></control><display><type>article</type><title>Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Aiello Bowles, Erin J ; Anderson, Melissa L ; Reed, Susan D ; Newton, Katherine M ; Fitzgibbons, E Dawn ; Seger, Deborah ; Buist, Diana S M</creator><creatorcontrib>Aiello Bowles, Erin J ; Anderson, Melissa L ; Reed, Susan D ; Newton, Katherine M ; Fitzgibbons, E Dawn ; Seger, Deborah ; Buist, Diana S M</creatorcontrib><description>Breast density tends to decrease when women stop taking hormone therapy (HT). Some women find HT cessation difficult to tolerate, possibly because of fluctuations in endogenous hormone levels and vasomotor symptoms. We hypothesized that women with dense breasts might have lower tolerance for short-term HT suspension than do women with fatty breasts. As part of the Radiologic Evaluation And breast Density (READ) trial, we randomly assigned 881 women aged 45-80 with a prior screening (index) mammogram to suspend HT for 1 or 2 months before their next screening (study) mammogram. We measured continuous breast density on index mammograms using computer-assisted thresholding. At study mammograms, women indicated tolerance for stopping HT from 1 (extremely difficult) to 7 (very easy). Using linear regression, we evaluated the association between index breast density and tolerance after cessation, adjusting for age, body mass index (BMI), HT type, randomization group, and vasomotor symptoms. A higher percentage of breast density was associated with lower unadjusted mean tolerance scores (tolerance 4.27, 95% confidence interval [CI] 3.77-4.77 for women with &gt; or =50% density, and 4.73, 95% CI 4.45-5.01 for women with &lt;10% density, not a statistically significant difference). In adjusted analyses, neither percent breast density nor dense breast area was associated with tolerance for HT suspension. Although HT use affects breast density, tolerance for suspending HT is not associated with breast density. Women with dense breasts have the greatest potential for decreases in density after HT cessation; they should tolerate stopping HT as well as women with fatty breasts.</description><identifier>ISSN: 1540-9996</identifier><identifier>EISSN: 1931-843X</identifier><identifier>DOI: 10.1089/jwh.2009.1681</identifier><identifier>PMID: 20575711</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Aged ; Aged, 80 and over ; Body Mass Index ; Breast - anatomy &amp; histology ; Breast Diseases - diagnostic imaging ; Estrogen Replacement Therapy ; Female ; Hot Flashes ; Humans ; Mammography ; Middle Aged ; Original ; Postmenopause ; Radiographic Image Enhancement ; Vasomotor System - drug effects ; Vasomotor System - physiopathology ; Washington ; Withholding Treatment</subject><ispartof>Journal of women's health (Larchmont, N.Y. 2002), 2010-08, Vol.19 (8), p.1467-1474</ispartof><rights>Copyright 2010, Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-2396cd8faec3943db8e9bd19a6d18dafdd5995a9aa91be78d528b02443427af33</citedby><cites>FETCH-LOGICAL-c386t-2396cd8faec3943db8e9bd19a6d18dafdd5995a9aa91be78d528b02443427af33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20575711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aiello Bowles, Erin J</creatorcontrib><creatorcontrib>Anderson, Melissa L</creatorcontrib><creatorcontrib>Reed, Susan D</creatorcontrib><creatorcontrib>Newton, Katherine M</creatorcontrib><creatorcontrib>Fitzgibbons, E Dawn</creatorcontrib><creatorcontrib>Seger, Deborah</creatorcontrib><creatorcontrib>Buist, Diana S M</creatorcontrib><title>Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension</title><title>Journal of women's health (Larchmont, N.Y. 2002)</title><addtitle>J Womens Health (Larchmt)</addtitle><description>Breast density tends to decrease when women stop taking hormone therapy (HT). Some women find HT cessation difficult to tolerate, possibly because of fluctuations in endogenous hormone levels and vasomotor symptoms. We hypothesized that women with dense breasts might have lower tolerance for short-term HT suspension than do women with fatty breasts. As part of the Radiologic Evaluation And breast Density (READ) trial, we randomly assigned 881 women aged 45-80 with a prior screening (index) mammogram to suspend HT for 1 or 2 months before their next screening (study) mammogram. We measured continuous breast density on index mammograms using computer-assisted thresholding. At study mammograms, women indicated tolerance for stopping HT from 1 (extremely difficult) to 7 (very easy). Using linear regression, we evaluated the association between index breast density and tolerance after cessation, adjusting for age, body mass index (BMI), HT type, randomization group, and vasomotor symptoms. A higher percentage of breast density was associated with lower unadjusted mean tolerance scores (tolerance 4.27, 95% confidence interval [CI] 3.77-4.77 for women with &gt; or =50% density, and 4.73, 95% CI 4.45-5.01 for women with &lt;10% density, not a statistically significant difference). In adjusted analyses, neither percent breast density nor dense breast area was associated with tolerance for HT suspension. Although HT use affects breast density, tolerance for suspending HT is not associated with breast density. Women with dense breasts have the greatest potential for decreases in density after HT cessation; they should tolerate stopping HT as well as women with fatty breasts.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Body Mass Index</subject><subject>Breast - anatomy &amp; histology</subject><subject>Breast Diseases - diagnostic imaging</subject><subject>Estrogen Replacement Therapy</subject><subject>Female</subject><subject>Hot Flashes</subject><subject>Humans</subject><subject>Mammography</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Postmenopause</subject><subject>Radiographic Image Enhancement</subject><subject>Vasomotor System - drug effects</subject><subject>Vasomotor System - physiopathology</subject><subject>Washington</subject><subject>Withholding Treatment</subject><issn>1540-9996</issn><issn>1931-843X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkUtr3TAQRkVIyXuZbdEuK9_oZVvaBEpIm0BCNy1kJ8bWOHawJUeSU-6_jy9JQ7uage_wzcAh5JyzDWfaXD7_6TeCMbPhleZ75IgbyQut5OP-upeKFcaY6pAcp_TMmBCcsQNyKFhZlzXnR6R5gGkKTxHmfmhpExFSpg59GvKWgnc0hxEj-BZpFyJNfYi5yBgnOoeUJ_RhhiXBSNdgCh5p7ld83tK0pHlXE_wp-dLBmPDsY56Q399vfl3fFvc_f9xdf7svWqmrXAhpqtbpDrCVRknXaDSN4wYqx7WDzrnSmBIMgOEN1tqVQjdMKCWVqKGT8oRcvffOSzOha9HnCKOd4zBB3NoAg_0_8UNvn8KrFUZxxdRacPFREMPLginbaUgtjiN4DEuytdJGlkpWK1m8k20MKUXsPq9wZnda7KrF7rTYnZaV__rva5_0Xw_yDbZRjX4</recordid><startdate>201008</startdate><enddate>201008</enddate><creator>Aiello Bowles, Erin J</creator><creator>Anderson, Melissa L</creator><creator>Reed, Susan D</creator><creator>Newton, Katherine M</creator><creator>Fitzgibbons, E Dawn</creator><creator>Seger, Deborah</creator><creator>Buist, Diana S M</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201008</creationdate><title>Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension</title><author>Aiello Bowles, Erin J ; Anderson, Melissa L ; Reed, Susan D ; Newton, Katherine M ; Fitzgibbons, E Dawn ; Seger, Deborah ; Buist, Diana S M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-2396cd8faec3943db8e9bd19a6d18dafdd5995a9aa91be78d528b02443427af33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Body Mass Index</topic><topic>Breast - anatomy &amp; histology</topic><topic>Breast Diseases - diagnostic imaging</topic><topic>Estrogen Replacement Therapy</topic><topic>Female</topic><topic>Hot Flashes</topic><topic>Humans</topic><topic>Mammography</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Postmenopause</topic><topic>Radiographic Image Enhancement</topic><topic>Vasomotor System - drug effects</topic><topic>Vasomotor System - physiopathology</topic><topic>Washington</topic><topic>Withholding Treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aiello Bowles, Erin J</creatorcontrib><creatorcontrib>Anderson, Melissa L</creatorcontrib><creatorcontrib>Reed, Susan D</creatorcontrib><creatorcontrib>Newton, Katherine M</creatorcontrib><creatorcontrib>Fitzgibbons, E Dawn</creatorcontrib><creatorcontrib>Seger, Deborah</creatorcontrib><creatorcontrib>Buist, Diana S M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of women's health (Larchmont, N.Y. 2002)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aiello Bowles, Erin J</au><au>Anderson, Melissa L</au><au>Reed, Susan D</au><au>Newton, Katherine M</au><au>Fitzgibbons, E Dawn</au><au>Seger, Deborah</au><au>Buist, Diana S M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension</atitle><jtitle>Journal of women's health (Larchmont, N.Y. 2002)</jtitle><addtitle>J Womens Health (Larchmt)</addtitle><date>2010-08</date><risdate>2010</risdate><volume>19</volume><issue>8</issue><spage>1467</spage><epage>1474</epage><pages>1467-1474</pages><issn>1540-9996</issn><eissn>1931-843X</eissn><abstract>Breast density tends to decrease when women stop taking hormone therapy (HT). Some women find HT cessation difficult to tolerate, possibly because of fluctuations in endogenous hormone levels and vasomotor symptoms. We hypothesized that women with dense breasts might have lower tolerance for short-term HT suspension than do women with fatty breasts. As part of the Radiologic Evaluation And breast Density (READ) trial, we randomly assigned 881 women aged 45-80 with a prior screening (index) mammogram to suspend HT for 1 or 2 months before their next screening (study) mammogram. We measured continuous breast density on index mammograms using computer-assisted thresholding. At study mammograms, women indicated tolerance for stopping HT from 1 (extremely difficult) to 7 (very easy). Using linear regression, we evaluated the association between index breast density and tolerance after cessation, adjusting for age, body mass index (BMI), HT type, randomization group, and vasomotor symptoms. A higher percentage of breast density was associated with lower unadjusted mean tolerance scores (tolerance 4.27, 95% confidence interval [CI] 3.77-4.77 for women with &gt; or =50% density, and 4.73, 95% CI 4.45-5.01 for women with &lt;10% density, not a statistically significant difference). In adjusted analyses, neither percent breast density nor dense breast area was associated with tolerance for HT suspension. Although HT use affects breast density, tolerance for suspending HT is not associated with breast density. Women with dense breasts have the greatest potential for decreases in density after HT cessation; they should tolerate stopping HT as well as women with fatty breasts.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>20575711</pmid><doi>10.1089/jwh.2009.1681</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1540-9996
ispartof Journal of women's health (Larchmont, N.Y. 2002), 2010-08, Vol.19 (8), p.1467-1474
issn 1540-9996
1931-843X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2941404
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Aged, 80 and over
Body Mass Index
Breast - anatomy & histology
Breast Diseases - diagnostic imaging
Estrogen Replacement Therapy
Female
Hot Flashes
Humans
Mammography
Middle Aged
Original
Postmenopause
Radiographic Image Enhancement
Vasomotor System - drug effects
Vasomotor System - physiopathology
Washington
Withholding Treatment
title Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T18%3A19%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mammographic%20breast%20density%20and%20tolerance%20for%20short-term%20postmenopausal%20hormone%20therapy%20suspension&rft.jtitle=Journal%20of%20women's%20health%20(Larchmont,%20N.Y.%202002)&rft.au=Aiello%20Bowles,%20Erin%20J&rft.date=2010-08&rft.volume=19&rft.issue=8&rft.spage=1467&rft.epage=1474&rft.pages=1467-1474&rft.issn=1540-9996&rft.eissn=1931-843X&rft_id=info:doi/10.1089/jwh.2009.1681&rft_dat=%3Cproquest_pubme%3E748935436%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=748935436&rft_id=info:pmid/20575711&rfr_iscdi=true